secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001178913-25-001941
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics receives Nasdaq delisting notice; plans appeal
--------------------------------------------------------------------

- Received delisting notice on May 22, 2025 for MVLS <$50M and MVPHS <$15M non-compliance.
- Failed to regain compliance within 180-day period ending May 19, 2025.
- Intends to appeal by May 29, 2025; trading suspension effective June 2, 2025 if appeal fails.
- Plans to request transfer to Nasdaq Capital Market; requires at least $2.5M shareholders' equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325001941/0001178913-25-001941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325001941/zk2533256.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-001941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer